Related Experiment Video
Updated: Jul 4, 2026

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
Published on: March 8, 2019
Matrix metalloproteinase-3 gene polymorphism and dilatative pathology of ascending thoracic aorta
Vaiva Lesauskaite1, Giedre Sinkūnaite, Rimantas Benetis
1Institute of Cardiology, Kaunas University of Medicine, Lithuania. vaiva.lesauskaite@med.kmu.lt
Abstract:
Matrix metalloproteinase-3 (MMP-3) degrades extracellular matrix and may lead to development of dilatative pathology of ascending thoracic aorta. Expression of MMP-3 depends upon the 5A/6A polymorphism in the promoter region. An increased number of 5A alleles leads to high expression of MMP-3. Thus, objective of the study was to determine whether the 5A/6A polymorphism in the promoter region of MMP-3 gene is associated with the development of dilatative pathology of ascending thoracic aorta. We studied 76 patients (age ranged from 31 to 81 years; median age, 64 years) who underwent aortic reconstruction surgery due to dilatative pathology of ascending thoracic aorta and a random sample of the population (n=604) aged 25-64 years, all from Lithuania. DNA was analyzed by using real-time polymerase chain reaction to genotype polymorphism 5A/6A at a position -1171 of the MMP3 gene promoter. The prevalence of MMP-3 genotypes was similar in the group of dilatative pathology of ascending thoracic aorta and random sample of population. The frequency of 5A allele did not differ significantly between both groups and was 0.506 and 0.514, respectively. Male carriers of 5A/5A genotype were significantly younger compared with those with the 6A/6A genotype. In conclusion, the frequency of MMP-3 promoter 5A/6A genotypes did not differ between the group of patients with dilatative pathology of ascending thoracic aorta and the random sample of population, but the males with dilatative pathology of ascending thoracic aorta and 5A/5A genotype required aortic reconstruction surgery at the younger age than the males carrying 6A/6A genotype in the MMP-3 promoter region.
Insights
The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not linked to dilatative aortic pathology. However, males with this condition and the 5A/5A genotype had surgery at a younger age.
Area of Science:
- Genetics
- Cardiovascular Science
- Molecular Biology
Background:
- Matrix metalloproteinase-3 (MMP-3) degrades extracellular matrix, potentially contributing to ascending thoracic aorta dilatative pathology.
- MMP-3 expression is influenced by the 5A/6A polymorphism in its promoter region, with more 5A alleles correlating with higher expression.
Purpose of the Study:
- To investigate the association between the MMP-3 gene's 5A/6A promoter polymorphism and the development of dilatative ascending thoracic aorta pathology.
- To determine if this genetic variation impacts the age of onset for aortic reconstruction surgery in affected males.
Main Methods:
- Genotyping of the 5A/6A polymorphism in the MMP-3 gene promoter using real-time polymerase chain reaction.
- Comparison of genotype and allele frequencies between patients with dilatative ascending thoracic aorta pathology and a general population sample from Lithuania.
Main Results:
- The prevalence of MMP-3 genotypes and the frequency of the 5A allele were similar between patients with aortic pathology and the control group.
- Male patients with the 5A/5A genotype underwent aortic reconstruction surgery at a significantly younger age compared to those with the 6A/6A genotype.
Conclusions:
- The 5A/6A polymorphism in the MMP-3 promoter is not significantly associated with the development of dilatative ascending thoracic aorta pathology.
- In males with this condition, the 5A/5A genotype is linked to an earlier age of requiring aortic reconstruction surgery.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Thoracic Aorta
Aneurysm I: Introduction

